Semecarpus Anacardium Juice
Active ingredient
Sold as Anacardium Orientale · ANACARDIUM ORI
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 2
- FDA reports (12 mo)
- 27
Overview
Semecarpus Anacardium Juice is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | May 30, 2024 |
USUnited States· FDA
2 products
Uses
INDICATIONS
Condition listed above or as directed by the physician
How to take
DOSAGE
Adults:
Mix 4-6 drops in 1/2 cup of water, take orally three times daily or as directed by a physician.
Children (2 years and older):
Take half the adult dose.
This is not medical advice. Consult a qualified healthcare professional.
Most-reported reactions to the US regulator (12 mo to June 4, 2026): 27 reports total. [2]
- Eye Pain 5
- Death 2
- Diarrhoea 2
- Eye Irritation 2
- Foreign Body Sensation In Eyes 2
- Illness 2
- Malaise 2
- Pain 2
- Vision Blurred 2
- Weight Decreased 2
- Adverse Drug Reaction 1
- Atrial Fibrillation 1
Side effects & warnings
If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional
WARNINGS
This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing.
Close the cap tightly after use.
This is not medical advice. Consult a qualified healthcare professional.
Who should not take it
Do not use if capseal is broken or missing. Close the cap tightly after use.
This is not medical advice. Consult a qualified healthcare professional.
Brands in United States (2)
Sources & citations
- [1]FDA DailyMed · 19a61215-b4ce-f6… · revised May 30, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.